Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for August 2011
August 1, 2011
- Covidien Receives FDA Approval for Morphine Sulfate Oral Solution
- Lannett Receives FDA Approval for Phentermine Resin Extended-Release Capsules, 15 mg and 30 mg
- Forest Laboratories Sends Letter to Shareholders
- Nycomed US Inc. Names Brian A. Markison as Chief Executive Officer
- New Survey Finds Life Sciences Companies Struggling to Accurately Forecast Spending for Clinical Studies
August 2, 2011
- Pfizer Reports Second-Quarter 2011 Results
- Pfizer Completes Sale of Capsugel Business to KKR
- Insmed Incorporated Announces Clinical Hold on ARIKACE Phase 3 Clinical Trials
- Akorn to Acquire a Minority Stake in Aciex Therapeutics
- National Survey Shows: Vast Majority of Preteens and Teens Engage in Activities That May Put Them at Risk for Contracting Meningitis
- Daiichi Sankyo and Ranbaxy to Expand Hybrid Business Model in Mexico
- Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters
- Mylan Announces U.S. PTO Intends to Reissue Two Perforomist Patents to Dey Pharma
- FDA, International Counterparts Report Progress on Drug Inspection Collaboration
- Lannett Announces Chief Financial Officer Resignation
- SEC Charges Biopharmaceutical Company and Executives with Securities Fraud
August 3, 2011
- Drug Giant Buys Lunch to Serve Doctors its Pitch
- Acucela Appoints Former Bristol-Myers Squibb and F. Hoffman-La Roche AG Executive, Jaisim Shah, to the Company's Board of Directors
- Use of Antipsychotic Medication For Reducing Symptoms of Military-Related Chronic Posttraumatic Stress Disorder Does Not Appear Effective
- Boys Encouraged to Get HPV Vaccine
- Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV)
- Allergan Reports Second Quarter 2011 Operating Results
- NPS Pharmaceuticals Announces New Calcilytics Agreement with GSK
- Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-536 Program
- Vectura Announces A New US Collaboration Agreement With A Leading International Pharmaceutical Company for the VR315 Combination Asthma/COPD Therapy
- New Survey Reveals Pharmacists Are Increasingly Struggling to Care for Patients Amid Predatory Audits, Unfair Reimbursement Practices
August 4, 2011
- FDA Drug Safety Communication:Use of long-term, high-dose Diflucan (fluconazole) during pregnancy may be associated with birth defects in infants
- FDA Approves Nation's First Scorpion Antivenom, Tested at UA
- Nurses Urge Teens Get Meningitis Vaccine
- VWR International, LLC to Acquire LabPartner (Shanghai) Co., Ltd.
- Novo Nordisk increased operating profit by 13% in the first six months of 2011 (4 August 2011)
- Completion of New Pharmaceutical Research Facility
- Dendreon Reports Second Quarter 2011 Financial Results
- Medicare Prescription Drug Premiums Will Not Increase, More Seniors Receiving Free Preventive Care, Discounts in the Donut Hole
- Augme Technologies Enters into Agreement to Purchase Assets of Mobile Marketing and Advertising Leader Hipcricket
August 5, 2011
- FDA Drug Safety Communication: Safety review update of Recombinant Human Growth Hormone (somatropin) and possible increased risk of death
- FDA Drug Safety Communication: Updated drug labels for pioglitazone-containing medicines
- Drug Companies Feeling the Profit Pressures
- Enzon Takes Bigger 2Q Loss as Pegintron Sales Slip
- Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
- Poisoning Victim's Family Sues Hospital, Alleged Source
- Medicine: Nice Rejects First Pill to Treat Multiple Sclerosis
- Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
- Forest Laboratories Issues Statement Regarding Litigation with Icahn
August 8, 2011
- Pozen Patents Upheld in Treximet Patent Litigation
- European Medicines Agency Signs Lease for New Office Space
- Total Victory for Schering Plough Pharmaceutical Reps in National Suit for Overtime Pay
- Serum and Merck Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine
- Second Trial in the Largest Hepatitis C Outbreak in U.S. Begins - Mainor Eglet Law Firm Files for Plaintiffs
- Unigene and GSK Enter Development Services and Clinical Supply Agreement in Preparation of Potential Phase 3 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women
- Forest Laboratories Sends Letter to Shareholders
- HHS-OIG Drops Potential Action against Forest CEO Howard Solomon
- UPS Survey: Global Healthcare Execs Face Risks with Complex Changes Ahead
August 9, 2011
- Akela Pharma Announces New Strategic Focus on Profitable PharmaForm Division
- Positive first half-year 2011 for Boehringer Ingelheim ? new growth from innovative medicines /Pradaxa approved in Europe
- Medidata Solutions Announces CFO Transition
- J&J One of Four Left In The AAA Club
- FTC Staff Says Proposed New York Legislation Would Reduce Competition and Likely Lead to Higher Prescription Drug Costs
- Genentech to Sell Oceanside Clinical Manufacturing Plant
- Leading 10 Biotechnology Companies Generated Annual Revenue of $77.85 Billion in 2010: PharmaLive Special Report
- Array Announces New Oncology Agreement with Genentech
- Chinese Pharma Firm's 2Q Profit Climbs 91 Percent
August 10, 2011
- Affymax Receives $10 Million Milestone Payment for FDA Filing of New Drug Application for Hematide/Peginesatide
- Paladin Labs Announces Premium Offer to Acquire Afexa Life Sciences for $0.55 per Share
- First half report 2011 - The solid momentum continues. Expected full year results to be in the upper end of the guidance range
- 38 Percent of ePharma Physicians Have Seen Sales Reps With iPads or other Tablets During Face-to-Face Meetings
- Medivation Make Breast Cancer Breakthrough
- ISS Recommends Forest Shareholders Vote For Company's Entire Slate of Ten Board Nominees
August 11, 2011
- Gilead Sciences Resolves FDA Warning Letter
- FDA Approves Gilead-J&J HIV Pill Complera
- Analyst Sees Low Complera Hopes
- Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
- Gilead Sciences Resolves U.S. Food and Drug Administration Warning Letter Related to San Dimas Manufacturing Facility
- FDA Will Decide on Lilly's Bydureon By Jan. 28
- Pfizer Will End Bristol, Tenn. Manufacturing Operations By 2014
- 'Amazing' Therapy Wipes Out Leukemia in Study
- Teijin and Astellas Conclude Distribution Agreement for New Gout and Hyperuricemia Drug in Southeast Asia and India
August 12, 2011
- Pfizer Pays Out to Families of Drug Trial Victims
- Mylan Launches Generic Version of Uroxatral Tablets
- Depression Linked to Increased Risk of Stroke in Women
- Watson's Anda Distribution to Build 234,000 sq ft Pharmaceutical Warehouse and Distribution Facility in Olive Branch, DeSoto County, MS
- Study: Illegal Online Pharmacies Can Manipulate Searches
- Icagen Stockholders Send Second Letter to Icagen Board to Contest Proposed Price of Acquisition by Pfizer
- PCMA: New Study Finds Mail-Service Pharmacies Improve Adherence to Diabetes Medications in Medicare Part D
- Mannkind to Start Insulin Trial
- Merck Employees Weigh Early-Retirement Offer
August 15, 2011
- FDA, State of Arkansas Sign Agreement to Advance Regulatory Science
- ParaPro's Lice Treatment Hits Shelves
- Pfizer Wins Viagra Patent Trial
- Forest Laboratories Sends Open Letter to Shareholders
- Row As Drug Companies Lavish Gifts on NHS Bosses
- ALCON -Consumer Alert: Cargo Theft of Novartis, Alcon and Falcon Products
- Intersect ENT Announces U.S. Food and Drug Administration Approval for First Drug Releasing Implant for Chronic Sinusitis Patients
- Fat and Healthy? York U Study Finds Slim Isn't Always Superior
August 16, 2011
- GE Healthcare to Acquire PAA Laboratories GmbH, Broadening Capabilities in Growing Biopharmaceutical Manufacture Segment
- Report: Carlyle in Talks to Buy PPD
- Xcelience to Add 45 Jobs in Expansion
- Eisai Establishes Subsidiary in Mexico
- Janssen Pharmaceuticals, Inc. Launches Online Tools on PrescribeResponsibly.com
- Forest Laboratories, Inc. Announces Additional Accelerated Share Repurchase
- Qiagen and Pfizer Partner to Develop Companion Diagnostic for Novel Compound in Global Clinical Trials for Lung Cancer
- Icagen Reiterates Its Recommendation That Stockholders Accept Pfizer's Offer of $6 Per Share
- Continued Climb for Pharma Vaccine Revenues
August 17, 2011
- Abbott Labs Says FDA Approves Longer-Acting Lupron
- Medication For Severe, Chronic Gout Associated With Improvement in Symptoms
- Group Questions Allegra Ad Claim
- Mylan Pushes Deal to Ensure Safety of Generic Drugs
- Shaky Finances for Dara BioSciences
- Daiichi Sankyo, Inc. Appoints Executive Vice President of Drug Development for the Americas
- Osmotica Pharmaceutical to Build Plant in Georgia
- Mylan Confirms First-to-File Patent Challenge Relating to FROVA Tablets
- FDA Extends Target Date for Review of Eye Drug
- Former Shionogi Employee Admits to Hack Attack on Company Servers
- Cytos Biotechnology Ltd Announces Strategic and Organizational Changes With the Aim of Preserving Value Around Its Lead Product and to Address the Up-Coming Maturity of the Convertible Bond
August 18, 2011
- Evolva Coordinated Sale Process To End
- Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol
- Galapagos and Genentech extend drug discovery collaboration
- Labopharm Announces Elimination of Angelini Labopharm's Oleptro Sales Force
- Labopharm Inc. enters into an agreement to be acquired by Paladin Labs Inc.
- Former PhRMA President Billy Tauzin Joins Leading 340B Drug Administrator
- Paladin Labs Inc. Issues Announcement Regarding Jonathan Ross Goodman
- United Therapeutics Expands RTP Facility
- Pfizer Says EU Starts Review of 2 Cancer Drugs
- FDA: Regulatory Science Plan Positions Agency to Foster Innovation Through Better Science
- Study finds majority of pharmaceutical ads do not adhere to FDA guidelines
- Endo Pharma Ends Collaboration on Back Pain Drug
- Preliminary Results Indicate Forest Shareholders Elect All Company Nominees
August 19, 2011
- NICE Agrees to Appeal Hearing on Lucentis
- CEL-SCI Addresses Warning Letter in Regard to Statements on Its Corporate Website
- DARA BioSciences Receives Fast Track Designation From the U.S. FDA for KRN5500 for the Treatment of Chemotherapy-Induced Neuropathic Pain in Patients With Cancer
- Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
- Detection of Radioactive Material from RDF Incineration Ashes at Chugai?s Fuji-Gotemba Research Laboratories
August 22, 2011
- Patients Sue Drugs Firm Over the Diet Pills that 'left them suicidal'
- Santarus and Depomed Announce New U.S. Commercialization Agreement for Glumetza Prescription Products
- Launch of Lexapro commenced in Japan
- St. Louis Company Develops Process to Thwart Meth Cookers
- As Big Pharma Downsizes, A Major Loss of Brain Power
- GSK takes minority stake in new spin out Autifony Therapeutics
- Brilinta (ticagrelor) Tablets Now Available in U.S. Pharmacies for Patients with Acute Coronary Syndrome
- Nycomed and Norgine sign a Licence Agreement for MOVIPREP in Russia/CIS
- Takeda Selected as Recipient of Government Subsidy for Developing Cell Culture-Based Influenza Vaccine
August 23, 2011
- FDA Grants Fast Track Designation to Bayer's Investigational Compound Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone
- Plan to Reuse Prescription Drugs Stuck on Final Hurdles
- Thermo Fisher Scientific Completes Acquisition of Phadia
- Chapel Hill Firm to Lead Alzheimer's Trials
- Drug Firm's Online Advert Predicting 9/11 Terror Attacks Sparks Outrage
- ImpactRx Appoints Gregory Ellis President and CEO
- NICE -Breast cancer drug not good use of resources, says draft guidance
August 24, 2011
- SurModics Cuts 9 Percent of Jobs, Reorganizes
- Par Pharmaceutical To Acquire Anchen Pharmaceuticals
- Patients Discharged From a Hospital at Increased Risk of Unintentional Discontinuation of Medications for Chronic Diseases
- Use of Certain Biologic Therapies for Psoriasis Do Not Appear to Increase Risk for Cardiovascular Problems
- Par Pharmaceutical Plans to Buy Rival Anchen
- Surmodics to Cut 9 Percent of Jobs; CFO Is Leaving
- Spain Orders Switch to Cheap Generic Drugs
- Antiseptic Wipe Lawsuit Targets Lilly, CVS, Triad
- SurModics Announces Strategic Realignment of Business
- Celexa (citalopram hydrobromide): Drug Safety Communication - Abnormal Heart Rhythms Associated With High Doses
- Namenda & Aricept Command Over 49% of the Market for Dementia: PharmaLive Special Report
August 25, 2011
- Google Forfeits $500 Million Generated by Online Ads & Prescription Drug Sales by Canadian Online Pharmacies
- Baxter to Acquire to Privately Held Baxa Corporation
- Forest Announces Certified Annual Meeting Results
- Novo Nordisk to Build New Corporate Centre in Bagsværd, Denmark
- Merlin Nexus and New Leaf Venture Partners Continue to Contest Proposed $56 Million Acquisition of Icagen by Pfizer
August 26, 2011
- Boehringer Ingelheim to Launch RE-ALIGN Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
- Study: Some Vaccines Cause Medical Problems in Rare Cases
- Lilly, Boehringer Diabetes Drug Gets European OK
- Few Health Problems Are Caused By Vaccines, IOM Report Finds
- National survey shows HPV vaccine rates trail other teen vaccines
- Results of Medication Studies in Top Medical Journals May Be Misleading to Readers
- UK Health Warning After Painkiller Mixup
- FDA Approves Dendreon's Atlanta Cancer Immunotherapy Manufacturing Facility
August 29, 2011
- Abbott Japan and Eisai Announce Launch of Pancreatic Digestive Enzyme Replacement Drug Lipacreon (pancrelipase)
- TAK-385 Enters into Phase 2 Clinical Trials in Japan for the Treatment of Endometriosis and Uterine Fibroids
- Icagen Reaffirms Recommendation to Shareholders to Tender Shares
- Ahead of the Bell: Blood Thinner Study Impresses
- Teva Announces Court Adopts All Relevant Teva Claim Construction Interpretations in Copaxone Patent Infringement Case against Sandoz/Momenta and Mylan/Natco; Court Denies Mylan's Summary Judgment Motion of Invalidity
- Monthly Roundup - August 2011
August 30, 2011
- EMD Millipore Strengthens Bioscience Business by Acquiring Amnis Corporation
- Abbott Japan and Eisai Announce Launch of Pancreatic Digestive Enzyme Replacement Drug Lipacreon
- Teva Says Copaxone Lawsuit Will Go to Trial
- Ipsen's half-year 2011 Results
- Inspiration Biopharmaceuticals and Ipsen Expand their Partnership in Preparation for the Commercial Launch of Inspiration's Hemophilia Pipeline in Europe
- India's Piramal in $1.5 Billion Overseas Drug Push
August 31, 2011
- Tough Start for Human Genome Drug
- Study Compares CEO Pay With Taxes
- Alcon Moving 100 Jobs to Fort Worth in Consolidation
- Why Have Britain's Biotech Stars Faded Away?: A Third of Listed Drug Firms in Sector Have Gone Bust
- Research Identifies Marketing Mix Strategy for Pharmaceutical Firms
- Daiichi Sankyo & Ranbaxy Announce a New Social Contribution Initiative Encompassing India, Cameroon and Tanzania
- IPS: CEOs Who Earn More Than Their Corporations Pay in Taxes
- Dr. Reddy's Announces Settlement of Lipitor (atorvastatin) ANDA Litigation with Pfizer
